BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11226331)

  • 1. Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice.
    Napoli C; Cirino G; Del Soldato P; Sorrentino R; Sica V; Condorelli M; Pinto A; Ignarro LJ
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2860-4. PubMed ID: 11226331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis.
    Napoli C; Aldini G; Wallace JL; de Nigris F; Maffei R; Abete P; Bonaduce D; Condorelli G; Rengo F; Sica V; D'Armiento FP; Mignogna C; de Rosa G; Condorelli M; Lerman LO; Ignarro LJ
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1689-94. PubMed ID: 11818533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice.
    Condorelli G; Aycock JK; Frati G; Napoli C
    FASEB J; 2001 Oct; 15(12):2162-70. PubMed ID: 11641242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midkine is expressed by infiltrating macrophages in in-stent restenosis in hypercholesterolemic rabbits.
    Narita H; Chen S; Komori K; Kadomatsu K
    J Vasc Surg; 2008 Jun; 47(6):1322-9. PubMed ID: 18353604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice.
    Napoli C; Ackah E; De Nigris F; Del Soldato P; D'Armiento FP; Crimi E; Condorelli M; Sessa WC
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12467-70. PubMed ID: 12209007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide-releasing aspirin derivative, NCX 4016, promotes reparative angiogenesis and prevents apoptosis and oxidative stress in a mouse model of peripheral ischemia.
    Emanueli C; Van Linthout S; Salis MB; Monopoli A; Del Soldato P; Ongini E; Madeddu P
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2082-7. PubMed ID: 15345513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice.
    Chadjichristos CE; Matter CM; Roth I; Sutter E; Pelli G; Lüscher TF; Chanson M; Kwak BR
    Circulation; 2006 Jun; 113(24):2835-43. PubMed ID: 16769907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders.
    Gresele P; Momi S
    Cardiovasc Drug Rev; 2006; 24(2):148-68. PubMed ID: 16961726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral transfer of endothelial nitric oxide synthase attenuates lesion formation in a novel murine model of postangioplasty restenosis.
    von der Thüsen JH; Fekkes ML; Passier R; van Zonneveld AJ; Mainfroid V; van Berkel TJ; Biessen EA
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):357-62. PubMed ID: 14699016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restenosis after percutaneous transluminal coronary angioplasty--anatomic and pathophysiological mechanisms. Strategies for prevention.
    Block PC
    Circulation; 1990 Mar; 81(3 Suppl):IV2-4. PubMed ID: 2407372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of platelet and endothelial cell COX-1 in hypercholesterolemia-induced microvascular dysfunction.
    Tailor A; Wood KC; Wallace JL; Specian RD; Granger DN
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3636-42. PubMed ID: 17933963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Schwartz L; Bourassa MG; Lespérance J; Aldridge HE; Kazim F; Salvatori VA; Henderson M; Bonan R; David PR
    N Engl J Med; 1988 Jun; 318(26):1714-9. PubMed ID: 2967433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
    Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
    J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine (SIN-1).
    Wan S; Shukla N; Angelini GD; Yim AP; Johnson JL; Jeremy JY
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):1033-9. PubMed ID: 17903525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.
    Wallace JL; McKnight W; Del Soldato P; Baydoun AR; Cirino G
    J Clin Invest; 1995 Dec; 96(6):2711-8. PubMed ID: 8675638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of platelet inhibitors on platelet uptake and restenosis after femoral angioplasty.
    Horrocks M; Horrocks EH; Murphy P; Lane IF; Ruttley MS; Fligelstone LJ; Watson HR
    Int Angiol; 1997 Jun; 16(2):101-6. PubMed ID: 9257670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiology of restenosis following percutaneous transluminal coronary angioplasty].
    Holm AM; Haunsø S; Hansen PR
    Ugeskr Laeger; 1998 Feb; 160(9):1302-6. PubMed ID: 9495077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin S expression is up-regulated following balloon angioplasty in the hypercholesterolemic rabbit.
    Burns-Kurtis CL; Olzinski AR; Needle S; Fox JH; Capper EA; Kelly FM; McQueney MS; Romanic AM
    Cardiovasc Res; 2004 Jun; 62(3):610-20. PubMed ID: 15158154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of smooth muscle cell proliferation after balloon angioplasty].
    Hanke H; Karsch KR
    Herz; 1992 Oct; 17(5):300-8. PubMed ID: 1473814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a role of macrophage migration inhibitory factor in vascular disease.
    Chen Z; Sakuma M; Zago AC; Zhang X; Shi C; Leng L; Mizue Y; Bucala R; Simon D
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):709-14. PubMed ID: 14751814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.